Using hormonal contraception does not appear to increase women's overall risk of contracting HIV, according to a U.S. National Institutes of Health study published on Thursday.
The study, published on the Web site of the journal AIDS, followed thousands of women in Africa and Asia and compared their patterns of contraceptive use to their risk of infection with HIV. "Understanding whether hormonal contraceptive use alters the risk of HIV acquisition among women is a critical public health issue," the study authors wrote.
Some 6,000 women in Uganda, Zimbabwe, and Thailand enrolled in the study and were offered a choice of the most commonly prescribed forms of hormonal contraception--birth control pills or DMPA (depot-medroxyprogesterone acetate) injections--as well as condoms.
Before enrolling, the women, aged 18 to 35, were either using no hormonal contraceptives or had used them for at least three months before the study began. None were infected with HIV when they enrolled, the researchers wrote.
The participants primarily were women who sought family planning services at clinics. They were tested for HIV four to five times a year for 15 to 24 months.
By the time the study ended, 213 African women and four Thai women had tested positive for HIV. Because there were too few cases in Thailand for a valid statistical interpretation, those cases were excluded from the final analysis, the researchers said.
When the 213 cases were considered together, researchers found no evidence that use of hormonal contraceptives increased a woman's chances of becoming infected with HIV, the study concluded.
"In summary, this large, multisite study found no overall increased risk of HIV acquisition associated with hormonal contraceptive uses, " the study authors wrote.
However, the authors noted that their study could not rule out an increase in risk for HIV infection among those already at higher than normal risks such as sex workers. (Reuters)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.